Research & News

Weiss Investor Signals Subscription Your Issue
Donald Trump’s “America First” version of policy has helped a lot of stocks – including those in sectors like financials, defense, and infrastructure. But in a little-noticed development, foreign...
Weiss Ratings Daily
We finally got one this week – a 1% decline in the Standard & Poor’s 500 Index. Tuesday’s drop was the first one of that magnitude since October. Some 87% of the index’s components fell on the...
Weiss Ratings Daily
We’ve long known that the Weiss Ratings Model gives us insights to a company’s future prospects, but I’m also finding we can use it to gauge the health of the general market. Let me explain… ...
Weiss Ratings Daily
Donald Trump made no secret on the campaign trail about his desire to shell out billions to make America’s military great again. Now that he’s president, he’s following through on his pledge....
Weiss Ratings Daily
The Federal Reserve did exactly what I predicted it would: Raise interest rates for the third time in this rate-hiking cycle. Wednesday’s move boosted the benchmark federal funds rate to a range...
Weiss Ratings Daily
Every few years, a new trend emerges, it gets hyped up, and everyone wants to invest in it. All too often, though, the sector doesn’t live up to the hype for one reason or another, and it tanks....
Weiss Ratings Daily
The countdown to Wednesday’s Federal Reserve interest rate hike is on! I trust you’ll be as well-prepared as anyone for it, given the advanced warning we’ve given you at Weiss Ratings. But here is...
Weiss Investor Signals Subscription Your Issue
Just a few short days from now, on March 14-15, the Federal Reserve will meet to discuss interest rates again. I believe a rate increase is locked in at this point. That’s because virtually every...
Weiss Ratings Daily
Janet Yellen and her Federal Reserve colleagues will meet to discuss interest rates next week. My take: Another rate hike is locked in! It would raise the federal funds rate from its current...
Weiss Ratings Daily
Small cap biotechnology stocks are some of my favorite investments. The innovations and cures you can find companies working on, and the rocketing of their stock prices once approvals are...